BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19393240)

  • 1. Flow cytometric determination of intracellular non-protein thiols in Leishmania promastigotes using 5-chloromethyl fluorescein diacetate.
    Sarkar A; Mandal G; Singh N; Sundar S; Chatterjee M
    Exp Parasitol; 2009 Aug; 122(4):299-305. PubMed ID: 19393240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of intracellular nitric oxide in leishmaniasis: its applicability in patients with visceral leishmaniasis.
    Sarkar A; Saha P; Mandal G; Mukhopadhyay D; Roy S; Singh SK; Das S; Goswami RP; Saha B; Kumar D; Das P; Chatterjee M
    Cytometry A; 2011 Jan; 79(1):35-45. PubMed ID: 21182181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short report: fluorescent Leishmania: application to anti-leishmanial drug testing.
    Singh N; Dube A
    Am J Trop Med Hyg; 2004 Oct; 71(4):400-2. PubMed ID: 15516633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of natural antimony resistance in Leishmania donovani isolates.
    Mittal MK; Rai S; Ashutosh ; Ravinder ; Gupta S; Sundar S; Goyal N
    Am J Trop Med Hyg; 2007 Apr; 76(4):681-8. PubMed ID: 17426170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania infantum promastigotes: flow cytometry as a possible tool for assessing the effects of drugs on cellular functions.
    Azas N; Di Giorgio C; Delmas F; Gasquet M; Timon-David P
    Exp Parasitol; 1997 Sep; 87(1):1-7. PubMed ID: 9287952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a semi-automated colorimetric assay for screening anti-leishmanial agents.
    Ganguly S; Bandyopadhyay S; Sarkar A; Chatterjee M
    J Microbiol Methods; 2006 Jul; 66(1):79-86. PubMed ID: 16316700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells.
    Mukhopadhyay R; Mukherjee S; Mukherjee B; Naskar K; Mondal D; Decuypere S; Ostyn B; Prajapati VK; Sundar S; Dujardin JC; Roy S
    Int J Parasitol; 2011 Nov; 41(13-14):1311-21. PubMed ID: 21920365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites.
    Singh R; Kumar D; Duncan RC; Nakhasi HL; Salotra P
    Int J Antimicrob Agents; 2010 Jul; 36(1):50-7. PubMed ID: 20427152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction.
    Verma NK; Singh G; Dey CS
    Exp Parasitol; 2007 May; 116(1):1-13. PubMed ID: 17161839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.
    Sharief AH; Gasim Khalil EA; Theander TG; Kharazmi A; Omer SA; Ibrahim ME
    Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on stibanate resistant Leishmania donovani isolates of Indian origin.
    Pal S; Mandal A; Duttagupta S
    Indian J Exp Biol; 2001 Mar; 39(3):249-54. PubMed ID: 11495284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antileishmanial activity of drug infused mini-agar plates on Leishmania donovani promastigotes.
    Muniaraj M; Sinha PK; Das P
    Trop Biomed; 2010 Dec; 27(3):657-61. PubMed ID: 21399608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmanicidal activity of edelfosine, miltefosine and ilmofosine.
    Azzouz S; Maache M; Garcia RG; Osuna A
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):60-5. PubMed ID: 15667597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles for mitochondria in pentamidine susceptibility and resistance in Leishmania donovani.
    Mukherjee A; Padmanabhan PK; Sahani MH; Barrett MP; Madhubala R
    Mol Biochem Parasitol; 2006 Jan; 145(1):1-10. PubMed ID: 16219371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.
    Samant M; Sahasrabuddhe AA; Singh N; Gupta SK; Sundar S; Dube A
    Parasitology; 2007 Aug; 134(Pt 9):1175-84. PubMed ID: 17362540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening.
    Singh N; Gupta R; Jaiswal AK; Sundar S; Dube A
    J Antimicrob Chemother; 2009 Aug; 64(2):370-4. PubMed ID: 19525291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sinefungin and taxol effects on cell cycle and cytoskeleton of Leishmania donovani promastigotes.
    Moulay L; Robert-Gero M; Brown S; Gendron MC; Tournier F
    Exp Cell Res; 1996 Aug; 226(2):283-91. PubMed ID: 8806432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinacrine and a novel apigenin dimer can synergistically increase the pentamidine susceptibility of the protozoan parasite Leishmania.
    Wong IL; Chan KF; Zhao Y; Chan TH; Chow LM
    J Antimicrob Chemother; 2009 Jun; 63(6):1179-90. PubMed ID: 19377065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry, a useful tool for detecting the lethal effect of pentamidine on Leishmania viannia complex promastigote forms.
    Delgado G; Puentes F; Moreno A; Patarroyo ME
    Pharmacol Res; 2001 Oct; 44(4):281-6. PubMed ID: 11592861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a modified MTT assay for screening antimonial resistant field isolates of Indian visceral leishmaniasis.
    Dutta A; Bandyopadhyay S; Mandal C; Chatterjee M
    Parasitol Int; 2005 Jun; 54(2):119-22. PubMed ID: 15866473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.